{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T13:18:14Z","timestamp":1761311894245,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The purpose of this study was to evaluate visual acuity after cataract surgery in eyes with Macular Telangiectasia (MacTel) Type 2.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Single-center retrospective cohort study of patients with MacTel Type 2 who underwent cataract surgery and were managed at the same institution. Patients underwent pre-operative assessment by a retinal specialist with examination and optical coherence tomography (OCT) at the same institution. The main outcome measure was the post-operative change in best corrected visual acuity (BCVA). Secondary study outcomes were achieving post-operative BCVA better than Snellen acuity of 20\/40 and time to BCVA loss by two lines or more (10 or more ETDRS letters).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 20 eyes (11 patients) underwent cataract surgery and were followed for a median of 25.5\u00a0months (IQR 17.5\u201344.2\u00a0months). The median post-operative BCVA improvement was 10.5 letters (IQR 3.50\u201320.25). Nuclear sclerosis severity [\u03b2\u2009=\u20098.99 (95% CI 3.35, 14.6), p\u2009=\u20090.00177] was associated with post-operative change in BCVA and central foveal ellipsoid zone (EZ) breaks [OR 1.33\u2009\u00d7\u200910<jats:sup>\u20139<\/jats:sup> (95% CI 5.12\u2009\u00d7\u200910<jats:sup>\u201310<\/jats:sup>\u20133.43\u2009\u00d7\u200910<jats:sup>\u22129<\/jats:sup>), p\u2009&lt;\u20090.001] on OCT was inversely correlated with post-operative BCVA\u2009&gt;\u200920\/40 using a multivariate generalized linear model. Central foveal EZ breaks [HR 1.77\u2009\u00d7\u200910<jats:sup>9<\/jats:sup> (95% CI 3.86\u2009\u00d7\u200910<jats:sup>8<\/jats:sup>, 8.11\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>), p\u2009&lt;\u20090.001] and MacTel Type 2 disease stage [HR 2.83, (95% CI 1.12, 7.12), p\u2009=\u20090.027] were independently associated with shorter time to vision loss of two lines or more in a multivariate Cox regression model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Visual acuity significant improved after cataract surgery in eyes with MacTel Type 2 regardless of disease severity. The presence of central foveal EZ breaks may predict poorer post-operative visual acuity and subsequent vision loss from disease progression.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40942-022-00386-0","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T09:02:47Z","timestamp":1654938167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Visual acuity after cataract surgery in Macular Telangiectasia Type 2 Stage 3 to 5"],"prefix":"10.1186","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6291-6688","authenticated-orcid":false,"given":"Jacob S.","family":"Heng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6104-5737","authenticated-orcid":false,"given":"J. Fernando","family":"Arevalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1314-1745","authenticated-orcid":false,"given":"James T.","family":"Handa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,11]]},"reference":[{"issue":"12","key":"386_CR1","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1016\/j.ophtha.2010.04.001","volume":"117","author":"MB Powner","year":"2010","unstructured":"Powner MB, Gillies MC, Tretiach M, Scott A, Guymer RH, Hageman GS, et al. Perifoveal m\u00fcller cell depletion in a case of macular telangiectasia type 2. Ophthalmology. 2010;117(12):2407\u201316.","journal-title":"Ophthalmology"},{"issue":"45","key":"386_CR2","doi-asserted-by":"publisher","first-page":"15715","DOI":"10.1523\/JNEUROSCI.2841-12.2012","volume":"32","author":"W Shen","year":"2012","unstructured":"Shen W, Fruttiger M, Zhu L, Chung SH, Barnett NL, Kirk JK, et al. Conditional M\u00fcller cell ablation causes independent neuronal and vascular pathologies in a novel transgenic model. J Neurosci. 2012;32(45):15715\u201327.","journal-title":"J Neurosci"},{"issue":"11","key":"386_CR3","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/j.ophtha.2013.04.013","volume":"120","author":"MB Powner","year":"2013","unstructured":"Powner MB, Gillies MC, Zhu M, Vevis K, Hunyor AP, Fruttiger M. Loss of M\u00fcller\u2019s cells and photoreceptors in macular telangiectasia type 2. Ophthalmology. 2013;120(11):2344\u201352.","journal-title":"Ophthalmology"},{"issue":"34","key":"386_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.preteyeres.2012.11.002","volume":"1","author":"P Charbel Issa","year":"2013","unstructured":"Charbel Issa P, Gillies MC, Chew EY, Bird AC, Heeren TFC, Peto T, et al. Macular telangiectasia type 2. Prog Retin Eye Res. 2013;1(34):49\u201377.","journal-title":"Prog Retin Eye Res"},{"issue":"12","key":"386_CR5","doi-asserted-by":"publisher","first-page":"7889","DOI":"10.1167\/iovs.12-10765","volume":"53","author":"FB Sallo","year":"2012","unstructured":"Sallo FB, Peto T, Egan C, Wolf-Schnurrbusch UEK, Clemons TE, Gillies MC, et al. The IS\/OS junction layer in the natural history of type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci. 2012;53(12):7889\u201395.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"386_CR6","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.1167\/iovs.15-16915","volume":"56","author":"TFC Heeren","year":"2015","unstructured":"Heeren TFC, Clemons T, Scholl HPN, Bird AC, Holz FG, Issa PC. Progression of vision loss in macular telangiectasia type 2. Invest Ophthalmol Vis Sci. 2015;56(6):3905\u201312.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Suppl 1","key":"386_CR7","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1097\/IAE.0000000000001746","volume":"38","author":"M Okada","year":"2018","unstructured":"Okada M, Robson AG, Egan CA, Sallo FB, Esposti SD, Heeren TFC, et al. Electrophysiological characterization of macular telangiectasia type 2 and structure-function correlation. Retina. 2018;38(Suppl 1):S33\u201342.","journal-title":"Retina"},{"issue":"Suppl1","key":"386_CR8","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1097\/IAE.0000000000001697","volume":"38","author":"T Peto","year":"2018","unstructured":"Peto T, Heeren TFC, Clemons TE, Sallo FB, Leung I, Chew EY, et al. Correlation of clinical and structural progression with visual acuity loss in macular telangiectasia type 2: MacTel project report No. 6\u2014the MacTel research group. Retina. 2018;38(Suppl1):S8\u201313.","journal-title":"Retina"},{"issue":"7","key":"386_CR9","doi-asserted-by":"publisher","first-page":"e998","DOI":"10.1111\/aos.14110","volume":"97","author":"D Pauleikhoff","year":"2019","unstructured":"Pauleikhoff D, Bonelli R, Dubis AM, Gunnemann F, Rothaus K, Issa PC, et al. Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2. Acta Ophthalmol (Copenh). 2019;97(7):e998-1005.","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"1","key":"386_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ajo.2010.02.013","volume":"150","author":"R Klein","year":"2010","unstructured":"Klein R, Blodi BA, Meuer SM, Myers CE, Chew EY, Klein BEK. The prevalence of macular telangiectasia type 2 in the Beaver Dam eye study. Am J Ophthalmol. 2010;150(1):55-62.e2.","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"386_CR11","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1016\/j.ophtha.2009.05.040","volume":"116","author":"GM Richter","year":"2009","unstructured":"Richter GM, Chung J, Azen SP, Varma R. Prevalence of visually significant cataract and factors associated with unmet need for cataract surgery: Los Angeles latino eye study. Ophthalmology. 2009;116(12):2327\u201335.","journal-title":"Ophthalmology"},{"issue":"5","key":"386_CR12","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1097\/IAE.0b013e31824690a8","volume":"32","author":"BC Toy","year":"2012","unstructured":"Toy BC, Koo E, Cukras C, Meyerle CB, Chew EY, Wong WT. Treatment of non-neovascular idiopathic macular telangiectasia type 2 with intravitreal ranibizumab: results of a phase ii clinical trial. Retina. 2012;32(5):996\u20131006.","journal-title":"Retina"},{"issue":"7","key":"386_CR13","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1097\/IAE.0b013e3181d87e04","volume":"30","author":"NZ Gregori","year":"2010","unstructured":"Gregori NZ, Feuer W, Rosenfeld PJ. Novel method for analyzing snellen visual acuity measurements. Retina Phila Pa. 2010;30(7):1046\u201350.","journal-title":"Retina Phila Pa"},{"issue":"10","key":"386_CR14","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/S0161-6420(93)31447-8","volume":"100","author":"JDM Gass","year":"1993","unstructured":"Gass JDM, Blodi BA. Idiopathic juxtafoveolar retinal telangiectasis: update of classification and follow-up study. Ophthalmology. 1993;100(10):1536\u201346.","journal-title":"Ophthalmology"},{"issue":"8","key":"386_CR15","doi-asserted-by":"publisher","first-page":"5105","DOI":"10.1167\/iovs.10-7005","volume":"52","author":"S Tick","year":"2011","unstructured":"Tick S, Rossant F, Ghorbel I, Gaudric A, Sahel J-A, Chaumet-Riffaud P, et al. Foveal shape and structure in a normal population. Invest Ophthalmol Vis Sci. 2011;52(8):5105\u201310.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"386_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1076\/opep.9.2.83.1523","volume":"9","author":"B Thylefors","year":"2002","unstructured":"Thylefors B, Chylack LT Jr, Konyama K, Sasaki K, Sperduto R, Taylor HR, et al. A simplified cataract grading system the WHO cataract grading group. Ophthalmic Epidemiol. 2002;9(2):83\u201395.","journal-title":"Ophthalmic Epidemiol"},{"issue":"1","key":"386_CR17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.32614\/RJ-2017-030","volume":"9","author":"G Inan","year":"2017","unstructured":"Inan G, Wang L. PGEE: an R package for analysis of longitudinal data with high-dimensional covariates. R J. 2017;9(1):393\u2013402.","journal-title":"R J"},{"key":"386_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling survival data: extending the cox model","author":"TM Therneau","year":"2000","unstructured":"Therneau TM, Grambsch PM. Modeling survival data: extending the cox model. New York: Springer; 2000."},{"issue":"4","key":"386_CR19","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/ng.3799","volume":"49","author":"TS Scerri","year":"2017","unstructured":"Scerri TS, Quaglieri A, Cai C, Zernant J, Matsunami N, Baird L, et al. Genome-wide analyses identify common variants associated with macular telangiectasia type 2. Nat Genet. 2017;49(4):559\u201367.","journal-title":"Nat Genet"},{"issue":"18","key":"386_CR20","doi-asserted-by":"publisher","first-page":"9103","DOI":"10.1073\/pnas.1821122116","volume":"116","author":"JS Heng","year":"2019","unstructured":"Heng JS, Rattner A, Stein-O\u2019Brien GL, Winer BL, Jones BW, Vernon HJ, et al. Hypoxia tolerance in the Norrin-deficient retina and the chronically hypoxic brain studied at single-cell resolution. Proc Natl Acad Sci USA. 2019;116(18):9103\u201314.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"386_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1136\/bjophthalmol-2019-315416","volume":"105","author":"Cindy X Cai","year":"2021","unstructured":"Cai CX, Choong J, Farsiu S, Chiu SJ, Chew EY, Jaffe GJ. Retinal cavitations in macular telangiectasia type 2 (MacTel): longitudinal structure\u2013function correlations. Br J Ophthalmol. 2021;105(1):109\u201312.","journal-title":"Br J Ophthalmol."},{"key":"386_CR22","doi-asserted-by":"crossref","unstructured":"Heeren TF, Kitka D, Florea D, Clemons TE, Chew EY, Bird AC, et al. Longitudinal correlation of ellipsoid zone loss and functional loss in macular telangiectasia type 2. Retina. 2018;38(Suppl 1):S20.","DOI":"10.1097\/IAE.0000000000001715"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-022-00386-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-022-00386-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-022-00386-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T09:14:10Z","timestamp":1654938850000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-022-00386-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,11]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["386"],"URL":"https:\/\/doi.org\/10.1186\/s40942-022-00386-0","relation":{},"ISSN":["2056-9920"],"issn-type":[{"type":"electronic","value":"2056-9920"}],"subject":[],"published":{"date-parts":[[2022,6,11]]},"assertion":[{"value":"12 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained from the Johns Hopkins School of Medicine Institutional Review Board (Protocol number IRB00151621). Patient consent was not required due to the retrospective nature of the study and the use of only anonymized data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}